Form D — Vesalius Longevity Labs (SPV) Inc.
0002060755-26-000018 · filed Mar 19, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $6,712,500
- Reported amount sold
- $6,712,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vesalius Longevity Labs (SPV) Inc.
- CIK
- 2056924
- Entity
- Corporation
- Jurisdiction
- BRITISH COLUMBIA, CANADA
- Year incorporated
- 2024
- Address
- 1500 - 1055 WEST GEORGIA STREET
VANCOUVER, British Columbia, Canada V6E 4N7 - Phone
- 5076666151
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shannon Anderson · DirectorVancouver, British Columbia, Canada Find on LinkedIn ↗
-
Christina Phalen · Executive OfficerVancouver, British Columbia, Canada Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗